Also trades as: RHC.AX (ASX) · $vol 32M · RMSYF (OTC) · $vol 0M

$9.71

+0.00 (+0.00%)

OTC · Healthcare · Medical - Care Facilities · Tech Score Buy · Power 71 · $8.9B mcap · 182M float · 0.0000% daily turnover · Short 45% of daily vol

Revenue

$18.2B +2.8% ▲

5Y CAGR: +7.2%

Gross Profit

$1.7B -87.3% ▼

5Y CAGR: +15.8%

Operating Income

$993M +14.0% ▲

5Y CAGR: -9.0%

Net Income

$322M +1241.7% ▲

5Y CAGR: -6.4%

EPS (Diluted)

$0.33 +1230.0% ▲

5Y CAGR: -7.2%

EBITDA

$2.1B +37.4% ▲

5Y CAGR: +3.5%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$13.2B	$15.0B	$16.7B	$17.7B	$18.2B
YoY Growth	+2.4%	+13.7%	+11.2%	+6.1%	+2.8%
Cost of Revenue	$12.3B	$13.7B	$14.6B	$4.0B	$16.4B
Gross Profit	$901M	$1.3B	$2.0B	$13.7B	$1.7B
Gross Margin	6.8%	8.5%	12.1%	77.3%	9.5%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$578M	$611M	$10.3B	$11.0B	$741M
Operating Expenses	$9.7B	$611M	$12.0B	$12.8B	$741M
Operating Income	$231M	$1.6B	$833M	$870M	$993M
Operating Margin	1.8%	11.0%	5.0%	4.9%	5.5%
Interest Expense	$390M	$518M	$613M	$335M	$595M
Income Before Tax	$523M	$527M	$385M	$102M	$502M
Tax Expense	$159M	$182M	$121M	$56M	$188M
Net Income	$274M	$298M	$889M	$24M	$322M
Net Margin	2.1%	2.0%	5.3%	0.1%	1.8%
EPS (Diluted)	$0.29	$0.31	$0.97	$0.03	$0.33
EBITDA	$1.6B	$1.8B	$1.8B	$1.6B	$2.1B
Shares Outstanding	913M	914M	914M	918M	923M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$7.1B	$7.9B	$8.1B	$8.6B	$8.5B	$9.2B	$9.2B	$9.4B
Cost of Revenue	$6.6B	$7.2B	$7.3B	$7.5B	$7.5B	$8.1B	$8.3B	$8.4B
Gross Profit	$550M	$710M	$772M	$1.0B	$1.0B	$1.1B	$849M	$920M
Gross Margin	7.7%	9.0%	9.5%	12.2%	11.9%	11.9%	9.3%	9.8%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$288M	$322M	$330M	$0	$0	$242M	$373M	$382M
Operating Expenses	$288M	$322M	$330M	$0	$0	$242M	$373M	$382M
Operating Income	$262M	$387M	$442M	$1.0B	$1.0B	$1.1B	$476M	$538M
Operating Margin	3.7%	4.9%	5.5%	12.2%	11.9%	11.9%	5.2%	5.7%
Interest Expense	$234M	$280M	$314M	$306M	$297M	$307M	$295M	$312M
Income Before Tax	$327M	$200M	$203M	$182M	-$106M	$208M	$220M	$293M
Tax Expense	$102M	$80M	$67M	$54M	-$6M	$62M	$83M	$109M
Net Income	$194M	$104M	$758M	$130M	-$105M	$129M	$158M	$171M
Net Margin	2.7%	1.3%	9.4%	1.5%	-1.2%	1.4%	1.7%	1.8%
EPS (Diluted)	$0.21	$0.11	$0.14	$0.13	$-0.12	$0.15	$0.17	$0.17
EBITDA	$739M	$926M	$973M	$512M	$1.0B	$578M	$1.1B	$1.1B
Shares Outstanding	913M	915M	915M	916M	919M	921M	923M	924M

RMYHY OTC